FDA Approved: PRED FORTE — Supplemental Application (Allergan, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for PRED FORTE (prednisolone acetate ophthalmic suspension) submitted by Allergan, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Inflammation
• Postoperative Ocular Inflammation
• Seasonal Allergic Conjunctivitis

Drugs mentioned

• PRED FORTE (Prednisolone acetate)

Snippet

SUPPL AP for PRED FORTE (PREDNISOLONE ACETATE)